ORIC Pharmaceuticals (4TZ.F) Q1 2025 Earnings

18FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.49
-0.44
-0.39
-0.34

Details

Expected EPS
-0.47887667399000006
Actual EPS
-0.4881057
Surprise EPS
-0.01
Surprise Percent
+1.93%

Description

ORIC Pharmaceuticals (4TZ.F) has reported earnings of -0.4881057 per share for Q1 2025.

0 Comments

Share your thoughts